B.R.A.I.N. Biotechnology Research And Information Network AG (DE000520)

BRIEF

published on 12/12/2024 at 09:05, 9 days 6 hours ago

BRAIN Biotech AG se recentre sur une croissance rentable

Croissance Rentable Prévisions Financières CERVEAU Biotechnologie Initiatives Stratégiques Entreprise D'enzymes
BRIEF

published on 12/12/2024 at 09:05, 9 days 6 hours ago

BRAIN Biotech AG Refocuses on Profitable Growth

Profitable Growth Financial Forecast Strategic Initiatives BRAIN Biotech Enzyme Business
PRESS RELEASE

published on 12/12/2024 at 09:00, 9 days 6 hours ago

BRAIN Biotech AG Sharpens Focus on Profitable Growth
BRAIN Biotech AG sharpens focus on profitable growth by creating new growth segment BRAINBiocatalysts. Targets include EUR 100 million revenues, 15% adjusted EBITDA margin, and high R&D ratio

Profitable Growth Financial Forecast BRAIN Biotech AG Enzyme Business BRAINBiocatalysts
BRIEF

published on 10/31/2024 at 19:25, 1 month 20 days ago

Un accord de licence exclusif renforce les activités pharmaceutiques de BRAIN Biotech

CERVEAU Biotechnologie Technologie CRISPR-Cas G-dase E® Licences Pharmaceutiques Akribion Thérapeutique
BRIEF

published on 10/31/2024 at 19:25, 1 month 20 days ago

Exclusive Licensing Agreement Boosts BRAIN Biotech's Pharma Ventures

BRAIN Biotech CRISPR-Cas Technology G-dase E® Pharma Licensing Akribion Therapeutics
PRESS RELEASE

published on 10/31/2024 at 19:20, 1 month 20 days ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)
BRIEF

published on 10/31/2024 at 19:16, 1 month 20 days ago

BRAIN Biotech AG Secures Licensing Deal with Akribion Therapeutics

Royalties Biotech Licensing CRISPR-Cas Technology Pharma Agreement Milestone Fees
BRIEF

published on 10/31/2024 at 19:16, 1 month 20 days ago

BRAIN Biotech AG conclut un accord de licence avec Akribion Therapeutics

Redevance Licences Biotechnologiques Technologie CRISPR-Cas Accord Pharmaceutique Frais D'étape
PRESS RELEASE

published on 10/31/2024 at 19:11, 1 month 20 days ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 2 months 18 days ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt

1 2 ... 7

Published on 12/21/2024 at 01:30, 14 hours 23 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 23 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 48 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 53 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 23 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 15 hours 1 minute ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 15 hours 8 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 42 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 57 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 53 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 35 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 35 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 53 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 53 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 58 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News